LncRNA Gm16023通过通过miR-377-3p/Sirt1轴调节巨细胞极化来改善高血糖症加重的败血性肠损伤

Fang Tan1, Lei Zheng2, Dongdong Yuan3

  • 1Department of Anesthesiology, the Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen 518107, China; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, China.

概括

高血糖症通过促进巨细胞活动,增加了败血症和肠道损伤的风险. 一种针对Gm16023/miR-377-3p/Sirt1通路的新型RNA疗法显示出治疗糖尿病败血症的前景.